argan inc - AGX

AGX

Close Chg Chg %
670.38 31.92 4.76%

Closed Market

702.30

+31.92 (4.76%)

Volume: 314.89K

Last Updated:

May 1, 2026, 3:59 PM EDT

Company Overview: argan inc - AGX

AGX Key Data

Open

$671.83

Day Range

663.14 - 704.59

52 Week Range

157.88 - 704.59

Market Cap

$9.35B

Shares Outstanding

13.96M

Public Float

13.35M

Beta

0.61

Rev. Per Employee

N/A

P/E Ratio

68.80

EPS

$9.99

Yield

27.99%

Dividend

$0.50

EX-DIVIDEND DATE

Apr 22, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

303.26K

 

AGX Performance

1 Week
 
2.60%
 
1 Month
 
16.49%
 
3 Months
 
93.02%
 
1 Year
 
309.10%
 
5 Years
 
1,235.95%
 

AGX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About argan inc - AGX

Argan, Inc. is a construction company, which engages in the operations of its wholly owned subsidiaries. The firm operates through the following business segments: Power, Industrial, and Teledata. The Power segment includes engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services to the power generation market. The Industrial segment offers primarily on-site services that support new plant construction and additions, maintenance turnarounds, shutdowns, and emergency mobilizations for industrial plants. The Teledata segment provides project management, construction, installation, maintenance, repair, and emergency response services. It also operates through the following geographical segments: United States, Republic of Ireland, and United Kingdom. The company was founded by Rainer H. Bosselmann in May 1961 and is headquartered in Arlington, VA.

AGX At a Glance

Argan, Inc.
4075 Wilson Boulevard
Arlington, Virginia 22203
Phone 1-301-315-0027 Revenue 944.61M
Industry Engineering & Construction Net Income 137.77M
Sector Industrial Services 2026 Sales Growth 8.056%
Fiscal Year-end 01 / 2027 Employees 1,409
View SEC Filings

AGX Valuation

P/E Current 68.796
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 35.642
Price to Sales Ratio 5.199
Price to Book Ratio 10.476
Price to Cash Flow Ratio 11.84
Enterprise Value to EBITDA 29.36
Enterprise Value to Sales 4.258
Total Debt to Enterprise Value 0.002

AGX Efficiency

Revenue/Employee 670,408.801
Income Per Employee 97,781.405
Receivables Turnover 5.335
Total Asset Turnover 0.92

AGX Liquidity

Current Ratio 1.592
Quick Ratio 1.576
Cash Ratio 1.258

AGX Profitability

Gross Margin 20.301
Operating Margin 14.26
Pretax Margin 16.992
Net Margin 14.585
Return on Assets 13.419
Return on Equity 33.846
Return on Total Capital 29.398
Return on Invested Capital 33.58

AGX Capital Structure

Total Debt to Total Equity 1.382
Total Debt to Total Capital 1.363
Total Debt to Total Assets 0.536
Long-Term Debt to Equity 0.837
Long-Term Debt to Total Capital 0.826
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Argan Inc - AGX

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
455.04M 573.33M 874.18M 944.61M
Sales Growth
-10.67% +26.00% +52.47% +8.06%
Cost of Goods Sold (COGS) incl D&A
371.66M 494.51M 731.70M 752.84M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.71M 2.40M 6.05M 2.29M
Depreciation
2.98M 2.01M 5.66M 1.91M
Amortization of Intangibles
732.00K 392.00K 391.00K 376.00K
COGS Growth
-10.01% +33.05% +47.96% +2.89%
Gross Income
83.38M 78.82M 142.48M 191.77M
Gross Income Growth
-13.48% -5.47% +80.77% +34.59%
Gross Profit Margin
+18.32% +13.75% +16.30% +20.30%
2023 2024 2025 2026 5-year trend
SG&A Expense
41.71M 42.36M 50.89M 57.06M
Research & Development
- - - -
-
Other SG&A
41.71M 42.36M 50.89M 57.06M
SGA Growth
-5.11% +1.57% +20.13% +12.14%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 3.40M
-
EBIT after Unusual Expense
41.67M 36.46M 88.19M 134.70M
Non Operating Income/Expense
4.33M 12.47M 23.01M 25.81M
Non-Operating Interest Income
- - 21.20M 24.00M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
46.00M 48.93M 111.20M 160.51M
Pretax Income Growth
-2.26% +6.38% +127.26% +44.34%
Pretax Margin
+10.11% +8.53% +12.72% +16.99%
Income Tax
11.30M 16.57M 25.75M 22.73M
Income Tax - Current - Domestic
13.79M 12.71M 23.09M 15.31M
Income Tax - Current - Foreign
740.00K 2.54M 791.00K 1.15M
Income Tax - Deferred - Domestic
(780.00K) (622.00K) 1.38M 6.45M
Income Tax - Deferred - Foreign
(2.45M) 1.96M 483.00K (165.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
34.70M 32.36M 85.46M 137.77M
Minority Interest Expense
- - - 1.61M
-
Net Income
33.10M 32.36M 85.46M 137.77M
Net Income Growth
-13.46% -2.24% +164.10% +61.22%
Net Margin Growth
+7.27% +5.64% +9.78% +14.59%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
33.10M 32.36M 85.46M 137.77M
Preferred Dividends
- - - -
-
Net Income Available to Common
33.10M 32.36M 85.46M 137.77M
EPS (Basic)
2.3502 2.4211 6.3548 10.0039
EPS (Basic) Growth
-3.43% +3.02% +162.48% +57.42%
Basic Shares Outstanding
14.08M 13.37M 13.45M 13.77M
EPS (Diluted)
2.3348 2.3884 6.1455 9.7387
EPS (Diluted) Growth
-2.85% +2.30% +157.31% +58.47%
Diluted Shares Outstanding
14.18M 13.55M 13.91M 14.15M
EBITDA
45.38M 38.86M 97.65M 136.99M
EBITDA Growth
-19.88% -14.37% +151.26% +40.29%
EBITDA Margin
+9.97% +6.78% +11.17% +14.50%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 473.20
Number of Ratings 6 Current Quarters Estimate 2.528
FY Report Date 07 / 2026 Current Year's Estimate 11.036
Last Quarter’s Earnings 2.22 Median PE on CY Estimate N/A
Year Ago Earnings 9.74 Next Fiscal Year Estimate 14.376
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 5 5
Mean Estimate 2.53 2.85 11.04 14.38
High Estimates 3.02 3.60 13.13 20.15
Low Estimate 2.12 2.18 8.97 10.86
Coefficient of Variance 13.36 18.36 17.74 27.78

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Argan Inc - AGX

Date Name Shares Transaction Value
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 10,252 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 21,554 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Lisa Larroque Alexander Director 530 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Lisa Larroque Alexander Director 700 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 21,824 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 22,554 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 22,914 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 25,727 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 7,284 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 18,839 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 6,252 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 26,852 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 11,585 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 49,998 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $602.11 per share 30,104,295.78
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 69,308 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 63,552 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 52,039 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 49,737 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 David Hibbert Watson PRESIDENT AND CEO; Director 49,001 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 21, 2026 Charles Edwin Iv Collins CHIEF EXECUTIVE OFFICER, GEMMA 29,383 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Argan Inc in the News